Skip to main content

Inogen Inc

INGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001294133

In the last 90 days, Inogen Inc insiders filed 0 open-market purchases and 1 sale; 129 institutions reported holding it in 13F filings for Q2 2026, worth $124.3M in total; no superinvestor holds it.

Holders of 5% or more of INGN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Inogen Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of INGN
HolderLatest formStakeChangeFirst filedLatest filingFiling
Yuwell (Hong Kong) Holdings Ltd13G9.90%2.63M sharesNewFeb 24, 20251 filingFeb 24, 2025SEC
BlackRock, Inc.13G/A6.20%1.66M shares–Jul 17, 20251 filingJul 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Inogen Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on INGN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 27, 20269:55 AM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Jul 17, 20257:54 PM ETBlackRock, Inc.13G/A6.20%1.66M shares–Jun 30, 2025SEC
May 15, 20254:16 PM ETCamber Capital Management LPand 1 other13G/A3.70%975.0K shares–Below 5%Mar 31, 2025SEC
May 15, 20252:04 PM ETBrown Capital Management LLC13G/A0.00%0 shares–Below 5%Mar 31, 2025SEC
Feb 24, 20256:10 AM ETYuwell (Hong Kong) Holdings Ltdand 1 other13G9.90%2.63M sharesNewFeb 21, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Inogen Inc shares.

No Form 144 notices for Inogen Inc are on file.